Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiko Murase

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
International Journal of Clinical Oncology|October 24, 2008
Basal-like subtype and BRCA1 dysfunction in breast cancersYasuo Miyoshi, Keiko Murase, Koushi Oh
Breast Cancer (Tokyo, Japan)|October 7, 2009
Prediction of hormone sensitivity for breast cancersYasuo Miyoshi, Keiko Murase, Masaru Saito, et al.
Medical Molecular Morphology|January 27, 2011
Mechanisms of estrogen receptor-α upregulation in breast cancersYasuo Miyoshi, Keiko Murase, Masaru Saito, et al.
Talanta|June 7, 2011
Flow injection spectrophotometric determination of formaldehyde based on its condensation with hydroxylamine and subsequent redox reaction with iron(III)-ferrozine complexNorio Teshima, Sara Keiko Murase Fernández, Minoru Ueda, et al.
Human Mutation|January 3, 2013
Molecular basis of two-exon skipping (exons 12 and 13) by c.1248+5g>a in OXCT1 gene: study on intermediates of OXCT1 transcripts in fibroblastsTomohiro Hori, Toshiyuki Fukao, Keiko Murase, et al.
Molecular Genetics and Metabolism|August 8, 2013
Development of MLPA for human ACAT1 gene and identification of a heterozygous Alu-mediated deletion of exons 3 and 4 in a patient with mitochondrial acetoacetyl-CoA thiolase (T2) deficiencyToshiyuki Fukao, Yuka Aoyama, Keiko Murase, et al.
Breast Cancer (Tokyo, Japan)|April 5, 2016
Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastasesArisa Nishimukai, Tomoko Higuchi, Hiromi Ozawa, et al.
Breast Cancer (Tokyo, Japan)|May 9, 2007
A case of solid neuroendocrine carcinoma of the breast in a 40-year-old womanYasuhisa Fujimoto, Ryuuichirou Yagyu, Keiko Murase, et al.
Journal of Inherited Metabolic Disease|July 24, 2010
A neonatal-onset succinyl-CoA:3-ketoacid CoA transferase (SCOT)-deficient patient with T435N and c.658-666dupAACGTGATT p.N220_I222dup mutations in the OXCT1 geneToshiyuki Fukao, Tomohiro Ishii, Naoko Amano, et al.
Clinical Breast Cancer|January 21, 2015
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast CancerArisa Nishimukai, Tomoko Yagi, Ayako Yanai, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Oncology|October 24, 2008
Basal-like subtype and BRCA1 dysfunction in breast cancersYasuo Miyoshi, Keiko Murase, Koushi Oh
Breast Cancer (Tokyo, Japan)|October 7, 2009
Prediction of hormone sensitivity for breast cancersYasuo Miyoshi, Keiko Murase, Masaru Saito, et al.
Medical Molecular Morphology|January 27, 2011
Mechanisms of estrogen receptor-α upregulation in breast cancersYasuo Miyoshi, Keiko Murase, Masaru Saito, et al.
Talanta|June 7, 2011
Flow injection spectrophotometric determination of formaldehyde based on its condensation with hydroxylamine and subsequent redox reaction with iron(III)-ferrozine complexNorio Teshima, Sara Keiko Murase Fernández, Minoru Ueda, et al.
Human Mutation|January 3, 2013
Molecular basis of two-exon skipping (exons 12 and 13) by c.1248+5g>a in OXCT1 gene: study on intermediates of OXCT1 transcripts in fibroblastsTomohiro Hori, Toshiyuki Fukao, Keiko Murase, et al.
Molecular Genetics and Metabolism|August 8, 2013
Development of MLPA for human ACAT1 gene and identification of a heterozygous Alu-mediated deletion of exons 3 and 4 in a patient with mitochondrial acetoacetyl-CoA thiolase (T2) deficiencyToshiyuki Fukao, Yuka Aoyama, Keiko Murase, et al.
Breast Cancer (Tokyo, Japan)|April 5, 2016
Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastasesArisa Nishimukai, Tomoko Higuchi, Hiromi Ozawa, et al.
Breast Cancer (Tokyo, Japan)|May 9, 2007
A case of solid neuroendocrine carcinoma of the breast in a 40-year-old womanYasuhisa Fujimoto, Ryuuichirou Yagyu, Keiko Murase, et al.
Journal of Inherited Metabolic Disease|July 24, 2010
A neonatal-onset succinyl-CoA:3-ketoacid CoA transferase (SCOT)-deficient patient with T435N and c.658-666dupAACGTGATT p.N220_I222dup mutations in the OXCT1 geneToshiyuki Fukao, Tomohiro Ishii, Naoko Amano, et al.
Clinical Breast Cancer|January 21, 2015
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast CancerArisa Nishimukai, Tomoko Yagi, Ayako Yanai, et al.
Pageof 3